Trial intelligence / Profile preview

Dose comparison study of intravenous indocyanine green for lung malignant tumor localization using fluorescence spectroscopy

jRCTs011230037Completed

Start
Apr 2024
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of indocyanine green in bronchial carcinoma. Primary endpoint: Primary diagnostic accuracy. Started Apr 2024; status: completed.

02

Drugs

indocyanine green
03

Conditions

bronchial carcinoma

Beyond the preview

Go deeper on jRCTs011230037.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs011230037.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call